Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02301260 · ClinicalTrials.gov registry record · NA

Speed of Processing Training to Improve Cognition in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02301260: Completed NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

NCT02301260 is a NA study of Multiple Sclerosis that has completed, run by Kessler Foundation. The registered enrollment target is 100 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02301260, a NA study of Multiple Sclerosis, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to investigate the effectiveness of a computerized technique designed to improve processing speed (i.e. the amount of time it takes for a person's brain to process information) in a multiple sclerosis (MS) population. The study is designed to study how well this technique can help people with MS increase their processing speed and their ability to function better in everyday life. This treatment protocol has been studied extensively with older adults, showing improvements on standard laboratory measures of processing speed and performance of activities of daily living.

Conditions Studied

Multiple Sclerosis

Interventions

  • BEHAVIORAL Placebo Control
  • BEHAVIORAL Speed of Processing Training (SPT)

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2014-04
Est. Completion 2020-02
Phase NA
Kessler Foundation

104 total trials

What the finished NCT02301260 record still lists

NCT02301260 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo Control is the first listed.

NCT02301260 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT02301260 about?

NCT02301260 is a clinical study titled "Speed of Processing Training to Improve Cognition in Multiple Sclerosis". The purpose of this research study is to investigate the effectiveness of a computerized technique designed to improve processing speed (i.e. the amount of time it takes for a person's brain to process information) in a multiple sclerosis (MS) population. The study is designed to study how well this...

What is the current status of trial NCT02301260?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-04. Estimated completion is 2020-02.

What conditions does trial NCT02301260 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02301260?

The interventions under investigation include: Placebo Control (BEHAVIORAL), Speed of Processing Training (SPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02301260?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02301260 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02301260's enrollment target sits among peer trials

100 128th of 315 higher than 181 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02301260, the US trial registry maintained by the National Library of Medicine. NCT02301260 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.